Current Assets
Trading Securities in Marketable Securities
Merck & Co. Trading Securities in Marketable Securities increased by 6.0% to $881.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.0%, from $872.00M to $881.00M. Over 5 years (FY 2020 to FY 2025), Trading Securities in Marketable Securities shows an upward trend with a 7.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ2 2018
Last reportedQ1 2026May 4, 2026
Metric ID:
trading_securities_in_marketable_securitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $694.00M | $578.00M | $596.00M | $643.00M | $671.00M | $705.00M | $832.00M | $942.00M | $949.00M | $863.00M | $832.00M | $851.00M | $936.00M | $848.00M | $863.00M | $872.00M | $870.00M | $834.00M | $831.00M | $881.00M |
| QoQ Change | — | -16.7% | +3.1% | +7.9% | +4.4% | +5.1% | +18.0% | +13.2% | +0.7% | -9.1% | -3.6% | +2.3% | +10.0% | -9.4% | +1.8% | +1.0% | -0.2% | -4.1% | -0.4% | +6.0% |
| YoY Change | — | — | — | — | -3.3% | +22.0% | +39.6% | +46.5% | +41.4% | +22.4% | +0.0% | -9.7% | -1.4% | -1.7% | +3.7% | +2.5% | -7.1% | -1.7% | -3.7% | +1.0% |
Range$578.00M – $949.00M
CAGR+5.2%
Avg YoY Growth+9.4%
Median YoY Growth+0.5%
Trading Securities in Marketable Securities at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s trading securities in marketable securities?
- Merck & Co. (MRK) reported trading securities in marketable securities of $881.00M in Q1 2026.
- How has Merck & Co.'s trading securities in marketable securities changed year-over-year?
- Merck & Co.'s trading securities in marketable securities increased by 1.0% year-over-year, from $872.00M to $881.00M.
- What is the long-term trend for Merck & Co.'s trading securities in marketable securities?
- Over 5 years (2020 to 2025), Merck & Co.'s trading securities in marketable securities has grown at a 7.2% compound annual growth rate (CAGR), from $586.00M to $831.00M.